Progenics Pharmaceuticals (PGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 48,947 | 67,671 | 75,646 | 69,906 | 9,486 |
| Gross Profit | 48,947 | 67,671 | 75,646 | 69,906 | 9,486 |
| Operating Expenses | 81,277 | 118,578 | 127,104 | 99,225 | 81,013 |
| Operating Income | -32,330 | -50,907 | -51,458 | -29,319 | -71,527 |
| Other Income | 1,718 | 6,235 | 7,770 | 7,701 | 2,299 |
| Pre-tax Income | -30,612 | -44,672 | -43,688 | -21,618 | -69,228 |
| Income Tax | N/A | N/A | N/A | N/A | 201 |
| Net Income Continuous | -30,612 | -44,672 | -43,688 | -21,618 | -69,429 |
| Net Income | $-30,612 | $-44,672 | $-43,688 | $-21,618 | $-69,429 |
| EPS Basic Total Ops | -0.98 | -1.48 | -1.59 | -0.84 | -3.33 |
| EPS Basic Continuous Ops | -0.98 | -1.48 | -1.59 | -0.84 | -3.33 |
| EPS Diluted Total Ops | -0.98 | -1.48 | -1.59 | -0.84 | -3.33 |
| EPS Diluted Continuous Ops | -0.98 | -1.48 | -1.59 | -0.84 | -3.33 |
| EBITDA(a) | $-26,363 | $-45,338 | $-48,876 | $-27,775 | $-67,631 |